Selectis Health, Inc.
GBCS
$2.20
-$0.05-2.22%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 321.30K | 480.20K | 639.10K | 637.00K | 634.50K |
| Total Other Revenue | 39.17M | 37.82M | 36.69M | 36.03M | 36.15M |
| Total Revenue | 39.49M | 38.30M | 37.33M | 36.67M | 36.78M |
| Cost of Revenue | 30.36M | 30.23M | 30.36M | 30.37M | 31.38M |
| Gross Profit | 9.13M | 8.06M | 6.97M | 6.30M | 5.41M |
| SG&A Expenses | 10.29M | 12.05M | 12.21M | 12.34M | 12.70M |
| Depreciation & Amortization | 1.57M | 1.64M | 1.62M | 1.65M | 1.67M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 42.22M | 43.92M | 44.19M | 44.36M | 45.74M |
| Operating Income | -2.73M | -5.63M | -6.87M | -7.69M | -8.96M |
| Income Before Tax | -2.42M | -5.48M | -6.14M | -9.03M | -3.97M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.42 | -5.48 | -6.14 | -9.03 | -3.97 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.42M | -5.48M | -6.14M | -9.03M | -3.97M |
| EBIT | -2.73M | -5.63M | -6.87M | -7.69M | -8.96M |
| EBITDA | -1.16M | -3.99M | -5.25M | -6.04M | -7.29M |
| EPS Basic | -0.80 | -1.80 | -2.02 | -2.96 | -1.31 |
| Normalized Basic EPS | -0.93 | -1.59 | -1.83 | -1.99 | -2.26 |
| EPS Diluted | -0.81 | -1.81 | -2.03 | -2.97 | -1.32 |
| Normalized Diluted EPS | -0.93 | -1.59 | -1.83 | -1.99 | -2.26 |
| Average Basic Shares Outstanding | 12.27M | 12.26M | 12.24M | 12.23M | 12.22M |
| Average Diluted Shares Outstanding | 12.27M | 12.26M | 12.24M | 12.23M | 12.22M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | 0.00% | 0.00% | 0.00% | -0.17% |